Journal Article

Coronary artery disease and intermittent claudication: how to manage the patient

P. Perrone-Filardi and M. Chiariello

in European Heart Journal Supplements

Published on behalf of European Society of Cardiology

Volume 4, issue suppl_B, pages B58-B62
Published in print March 2002 | ISSN: 1520-765X
Published online March 2002 | e-ISSN: 1554-2815 | DOI:
Coronary artery disease and intermittent claudication: how to manage the patient

Show Summary Details


Coexistence of peripheral arterial disease (PAD) and coronary artery disease (CAD) is common. PAD worsens the prognosis of patients with and without CAD. Thus, patients with PAD should be treated for secondary prevention, regardless of the diagnosis of CAD. PAD should be sought in smokers or diabetics aged between 59 and 69 years, in those older than 70 years, in those with known atherosclerotic disease, and in those with suspicion of PAD. As a screening tool, Doppler measurement of the ratio between ankle and arm pressures offers the best approach. Conversely, pharmacological stress imaging should be employed to rule out CAD in PAD patients. Treatment of PAD implies risk factor modification, especially smoking cessation and lipid profile. Pharmacological treatments include preventive drugs and drugs that affect claudication. Unfortunately, few drugs have been proven effective for the latter. These include cilostazol and propionyll-camitine, which ameliorates symptoms and quality of life. It remains unresolved whether different treatment strategies for coexistent CAD impact favourably on prognosis in these problematic patients.

Keywords: Cardiovascular risk; coronary artery disease; peripheral artery disease

Journal Article.  0 words. 

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.